CASES OF RELAPSED AND REFRACTORY B CELL PRECURSOR-ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY

被引：0
|
作者：
Kurita, Daisuke [1 ]
Yamanishi, Jun [1 ]
Osuna, Mitsumasa [1 ]
Ikeda, Junji [1 ]
Tsujimoto, Shinichi [1 ]
Takeuchi, Masanobu [1 ]
Tanoshima, Reo [1 ]
Shiba, Norio [1 ]
机构：
[1] Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-076
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [1] Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Locatelli, Franco
    del Bufalo, Francesca
    Quintarelli, Concetta
    HAEMATOLOGICA, 2024, 109 (06) : 1689 - 1699
  • [2] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia
    Lin, John K.
    Lerman, Benjamin J.
    Barnes, James I.
    Boursiquot, Brian C.
    Tan, Yuan Jin
    Robinson, Alex Q. L.
    Davis, Kara L.
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (32) : 3192 - +
  • [3] Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Sarkar, Reith R.
    Gloude, Nicholas J.
    Schiff, Deborah
    Murphy, James D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (07): : 719 - 726
  • [4] Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
    Badar, Talha
    Shah, Nirav N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (02)
  • [5] Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
    Talha Badar
    Nirav N. Shah
    Current Treatment Options in Oncology, 2020, 21
  • [6] Allogeneic stem cell transplantation as consolidation after chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia
    Cazabat, Romain
    HEMATOLOGIE, 2024, 30 (05):
  • [7] Cost-effectiveness of chimeric antigen receptor T-cell therapy in pediatric relapsed/refractory acute lymphoblastic leukemia.
    Sarkar, Reith
    Gloude, Nicholas Joseph
    Murphy, James Don
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemia
    Myers, Regina M.
    Dolan, Joseph
    Teachey, David T.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (10) : 1029 - 1042
  • [9] Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
    Grover, Punita
    Veilleux, Olivier
    Tian, Lu
    Sun, Ryan
    Previtera, Melissa
    Curran, Emily
    Muffly, Lori
    BLOOD ADVANCES, 2022, 6 (05) : 1608 - 1618
  • [10] Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
    Zhao Xiangyu
    Wu Haotian
    Cheng Yifei
    Xu Zhengli
    Chen Yuhong
    Chang Yingjun
    Wang Yu
    Zhang Xiaohui
    Xu Lanping
    Huang Xiaojun
    中华医学杂志英文版, 2023, 136 (16)
12345